SPARC quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Sun Pharma Advanced Research Company Ltd (SPARC) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow
Sun Pharma Advanced Research Company Ltd reported sales of ₹40 Cr, operating profit of ₹-34 Cr (OPM -85%) and net profit of ₹-21 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
SPARC quarterly results (₹ Cr)
Metric
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
13
15
27
10
8
8
1,853
40
Expenses
116
89
80
62
74
65
80
74
Operating Profit
-103
-74
-53
-52
-66
-57
1,773
-34
OPM
-800%
-494%
-196%
-540%
-836%
-670%
96%
-85%
Other Income
0
0
0
9
0
-12
2
24
Interest
1
3
5
6
8
9
12
8
Depreciation
3
3
3
3
3
3
2
2
Profit before tax
-107
-79
-61
-52
-76
-80
1,761
-21
Tax
0%
0%
-1%
0%
0%
0%
0%
1%
Net Profit
-107
-80
-60
-52
-76
-80
1,761
-21
EPS in Rs
-3.31
-2.45
-1.84
-1.6
-2.34
-2.48
54.27
-0.64
SPARC profit & loss, annual (₹ Cr)
Metric
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
239
76
72
1,879
1,909
Expenses
453
478
395
280
293
Operating Profit
-214
-402
-323
1,599
1,617
OPM
-90%
-532%
-450%
85%
85%
Other Income
11
29
2
-2
13
Interest
8
2
9
34
36
Depreciation
12
13
12
10
10
Profit before tax
-223
-387
-343
1,553
1,584
Tax
0%
0%
0%
0%
-
Net Profit
-223
-387
-343
1,553
1,584
EPS in Rs
-6.86
-11.93
-10.55
47.86
48.81
Dividend Payout
0%
0%
0%
0%
-
SPARC balance sheet (₹ Cr)
Metric
Mar 2023
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Equity Capital
32
32
32
32
32
Reserves
480
93
-249
-377
1,306
Borrowings
16
61
269
417
559
Other Liabilities
302
328
284
250
273
Total Liabilities
830
515
336
322
2,171
Fixed Assets
106
108
99
162
85
CWIP
27
44
54
1
72
Investments
291
2
0
0
0
Other Assets
406
362
183
160
2,014
Total Assets
830
515
336
322
2,171
SPARC cash flows (₹ Cr)
Metric
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
-69
-429
-360
-239
Cash from Investing Activity
-548
392
158
-23
Cash from Financing Activity
617
42
199
261
Net Cash Flow
-1
5
-3
-1
Free Cash Flow
-84
-455
-370
-262
CFO/OP
35%
106%
114%
-17%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit